Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:36018370

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.

Jun Li · Gang Peng · Kuikui Zhu · Xiaohua Jie · Yingzhuo Xu · Xinrui Rao · Yunhong Xu · Yunshang Chen · Biyuan Xing · Gang Wu · Liangliang Shi

Cancer immunology, immunotherapy : CII · 2023 doi:10.1007/s00262-022-03282-6

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:36018370
kind
science-record
content_hash
sha256:d9a7a0dc3433bab526a51a67104be66b646a5d01825ac13f40625cb2f97c106a
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T18:15:10Z
updated_at
2026-11-01T21:28:43Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.
doi
10.1007/s00262-022-03282-6
pmid
36018370
authors array · 11 items
[0]
Jun Li
[1]
Gang Peng
[2]
Kuikui Zhu
[3]
Xiaohua Jie
[4]
Yingzhuo Xu
[5]
Xinrui Rao
[6]
Yunhong Xu
[7]
Yunshang Chen
[8]
Biyuan Xing
[9]
Gang Wu
[10]
Liangliang Shi
journal
Cancer immunology, immunotherapy : CII
year
2023
abstract
BACKGROUND: Programmed cell death protein 1 (PD-1) antibody has been approved for a variety of tumors, but its effective rate is unsatisfactory. New evidence suggests that mast cells are an important component of the tumor microenvironment and are associated with resistance to immunotherapy, but the underlying mechanism is not clear. METHODS: Bioinformatics analysis of patients with melanoma in TCGA-SKCM and GSE91061 was used to determine the prognostic value of mast cells and their association with anti-PD-1 immunotherapy. HMC-1 cells (mast cell line) and bone marrow-derived mast cells (BMMCs) were used to verify the effect of PD-1 antibody and cromolyn sodium in vitro. The mouse subcutaneous melanoma model was used to verify the effect of the PD-1 antibody on mast cells in vivo. RESULTS: Bioinformatics analysis showed that mast cells were a poor prognostic factor associated with resistance to anti-PD-1 immunotherapy. PD-1 was expressed on the mast cell membrane. The PD-1 antibody promoted the release of histamine and cytokines from mast cells via the PI3K/AKT pathway and calcium signaling pathway. The activation of mast cells induced by PD-1 antibody could be partially inhibited by cromolyn sodium. In vivo, cromolyn sodium increased the efficacy of PD-1 antibody and decreased the infiltration of mast cells and the density of microvessels. CONCLUSION: PD-1+ mast cell activated by PD-1 antibody plays a negative role in the tumor microenvironment via the enhanced function of releasing histamine and cytokines. Inhibition of mast cell may provide a new solution to solve the low response rate of anti-PD-1 immunotherapy.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
The CIBERSORT algorithm was used to process the transcriptome data to calculate the abundance of activated mast cell in each tumor sample.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:36018370
locator
sections[21] "Activated mast cell is associated with poor prognosis and immunotherapy resistance in melanoma" paragraph 2
quote
The CIBERSORT algorithm was used to process the transcriptome data to calculate the abundance of activated mast cell in each tumor sample.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:36018370
locator
sections[3] "Patients" paragraph 2
quote
The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).
state
complete
[2] object · 6 fields
id
claim-target-result
statement
Mast cell activation is associated with poor prognosis and immunotherapy resistance in melanoma.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:36018370
locator
sections[21] "Activated mast cell is associated with poor prognosis and immunotherapy resistance in melanoma" paragraph 3
quote
Taken together, these findings suggest that mast cell activation is associated with poor prognosis and immunotherapy resistance in melanoma.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
Mast cell activation is associated with poor prognosis and immunotherapy resistance in melanoma.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:36018370
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE91061
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE91061
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:36018370
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1007/s00262-022-03282-6
sha256
sha256:5ef2ddc956750acb517450fc8727ebe2b04c40daff56c9374af868c796fc61aa
bytes
35716
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1007/s00262-022-03282-6
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC9947072
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE91061
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE91061
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE91061
version
null
note
The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).
access_statement_kind
repository_route_statement
sample_accessions array · 109 items
[0]
GSM2420259
[1]
GSM2420260
[2]
GSM2420261
[3]
GSM2420262
[4]
GSM2420263
[5]
GSM2420264
[6]
GSM2420265
[7]
GSM2420266
[8]
GSM2420267
[9]
GSM2420268
[10]
GSM2420269
[11]
GSM2420270
[12]
GSM2420271
[13]
GSM2420272
[14]
GSM2420273
[15]
GSM2420274
[16]
GSM2420275
[17]
GSM2420276
[18]
GSM2420277
[19]
GSM2420278
[20]
GSM2420279
[21]
GSM2420280
[22]
GSM2420281
[23]
GSM2420282
[24]
GSM2420283
[25]
GSM2420284
[26]
GSM2420285
[27]
GSM2420286
[28]
GSM2420287
[29]
GSM2420288
[30]
GSM2420289
[31]
GSM2420290
[32]
GSM2420291
[33]
GSM2420292
[34]
GSM2420293
[35]
GSM2420294
[36]
GSM2420295
[37]
GSM2420296
[38]
GSM2420297
[39]
GSM2420298
[40]
GSM2420299
[41]
GSM2420300
[42]
GSM2420301
[43]
GSM2420302
[44]
GSM2420303
[45]
GSM2420304
[46]
GSM2420305
[47]
GSM2420306
[48]
GSM2420307
[49]
GSM2420308
[50]
GSM2420310
[51]
GSM2420311
[52]
GSM2420312
[53]
GSM2420313
[54]
GSM2420316
[55]
GSM2420317
[56]
GSM2420318
[57]
GSM2420319
[58]
GSM2420320
[59]
GSM2420323
[60]
GSM2420324
[61]
GSM2420325
[62]
GSM2420326
[63]
GSM2420328
[64]
GSM2420329
[65]
GSM2420331
[66]
GSM2420332
[67]
GSM2420333
[68]
GSM2420334
[69]
GSM2420335
[70]
GSM2420336
[71]
GSM2420337
[72]
GSM2420338
[73]
GSM2420339
[74]
GSM2420340
[75]
GSM2420341
[76]
GSM2420342
[77]
GSM2420343
[78]
GSM2420344
[79]
GSM2420345
[80]
GSM2420346
[81]
GSM2420349
[82]
GSM2420350
[83]
GSM2420351
[84]
GSM2420352
[85]
GSM2420353
[86]
GSM2420354
[87]
GSM2420355
[88]
GSM2420356
[89]
GSM2420357
[90]
GSM2420358
[91]
GSM2420359
[92]
GSM2420360
[93]
GSM2420361
[94]
GSM2420362
[95]
GSM2420363
[96]
GSM2420364
[97]
GSM2420365
[98]
GSM2420366
[99]
GSM2420367
[100]
GSM2420368
[101]
GSM2420369
[102]
GSM2420370
[103]
GSM2420371
[104]
GSM2420372
[105]
GSM2420373
[106]
GSM2420374
[107]
GSM2420375
[108]
GSM2420376
sample_count
109
group_sizes
null
group_sizes_basis
null
platform
9052
taxon
Homo sapiens
title
Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:GSE91061 not downloaded
[1]
asset:data:geo:GSE91061 licence not read
analysis object · 4 fields
state
partial
methods array · 1 item
[0] object · 10 fields
id
method-1
family
null
specific
null
label
CIBERSORT algorithm
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
The CIBERSORT algorithm was used to process the transcriptome data to calculate the abundance of activated mast cell in each tumor sample.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocking_axis
method
blocked_on
method:not_determinable
axes object · 3 fields
method object · 5 fields
tier
R4
expressible
false
required_operations array · 0 items
missing_operations array · 0 items
basis
The reader quoted the method the paper names (CIBERSORT algorithm), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE91061
resolved_accessions array · 1 item
[0]
GSE91061
statements array · 1 item
[0]
The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).
basis
The paper names GSE91061 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:36018370
[1]
data:geo:GSE91061
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE91061
gaps array · 1 item
[0]
method:not_determinable
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T18:01:51Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
null
calls
5
usage object · 3 fields
prompt_tokens
10390
completion_tokens
1149
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:36018370
type
paper
label
pmid:36018370
[1] object · 3 fields
id
source:pmid:36018370
type
manuscript
label
PMID 36018370 full text
[2] object · 3 fields
id
data:geo:GSE91061
type
dataset
label
GEO GSE91061
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:36018370
type
paper
label
pmid:36018370
[1] object · 3 fields
id
source:pmid:36018370
type
manuscript
label
PMID 36018370 full text
[2] object · 3 fields
id
data:geo:GSE91061
type
dataset
label
GEO GSE91061
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-36018370
type
extraction
used array · 1 item
[0]
source:pmid:36018370
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE91061
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE91061
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:36018370
parent_hash
sha256:0017bd2053532168ef1c9532df480c44eab74a145ff0e5ebcc425b3d35c11db5
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:GSE91061 licence not read
[1]
asset:data:geo:GSE91061 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
animal_model
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
he effect of the PD-1 antibody on mast cells in vivo. RESULTS: Bioinformatics analysis showed tha
[1]
d be partially inhibited by cromolyn sodium. In vivo, cromolyn sodium increased the efficacy of P
[2]
1 antibody and cromolyn sodium in vitro. The mouse subcutaneous melanoma model was used to veri
[3]
en the diameter of the tumor was 5–9 mm, the mice were randomly divided into four groups. There wer
order_basis
paper_text_order:734
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
cell_culture
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
ican Type Culture Collection (ATCC). The two cell lines were cultured in 1640 complete medium (10% fetal bovine se
[1]
e Collection (ATCC). The two cell lines were cultured in 1640 complete medium (10% fetal bovine serum
order_basis
paper_text_order:2358
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:36018370", "kind": "science-record", "revision": 3, "content_hash": "sha256:d9a7a0dc3433bab526a51a67104be66b646a5d01825ac13f40625cb2f97c106a", "created_at": "2026-11-01T18:15:10Z", "updated_at": "2026-11-01T21:28:43Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.", "doi": "10.1007/s00262-022-03282-6", "pmid": "36018370", "authors": ["Jun Li", "Gang Peng", "Kuikui Zhu", "Xiaohua Jie", "Yingzhuo Xu", "Xinrui Rao", "Yunhong Xu", "Yunshang Chen", "Biyuan Xing", "Gang Wu", "Liangliang Shi"], "journal": "Cancer immunology, immunotherapy : CII", "year": 2023, "abstract": "BACKGROUND: Programmed cell death protein 1 (PD-1) antibody has been approved for a variety of tumors, but its effective rate is unsatisfactory. New evidence suggests that mast cells are an important component of the tumor microenvironment and are associated with resistance to immunotherapy, but the underlying mechanism is not clear.\nMETHODS: Bioinformatics analysis of patients with melanoma in TCGA-SKCM and GSE91061 was used to determine the prognostic value of mast cells and their association with anti-PD-1 immunotherapy. HMC-1 cells (mast cell line) and bone marrow-derived mast cells (BMMCs) were used to verify the effect of PD-1 antibody and cromolyn sodium in vitro. The mouse subcutaneous melanoma model was used to verify the effect of the PD-1 antibody on mast cells in vivo.\nRESULTS: Bioinformatics analysis showed that mast cells were a poor prognostic factor associated with resistance to anti-PD-1 immunotherapy. PD-1 was expressed on the mast cell membrane. The PD-1 antibody promoted the release of histamine and cytokines from mast cells via the PI3K/AKT pathway and calcium signaling pathway. The activation of mast cells induced by PD-1 antibody could be partially inhibited by cromolyn sodium. In vivo, cromolyn sodium increased the efficacy of PD-1 antibody and decreased the infiltration of mast cells and the density of microvessels.\nCONCLUSION: PD-1+ mast cell activated by PD-1 antibody plays a negative role in the tumor microenvironment via the enhanced function of releasing histamine and cytokines. Inhibition of mast cell may provide a new solution to solve the low response rate of anti-PD-1 immunotherapy.", "claims": [{"id": "claim-method", "statement": "The CIBERSORT algorithm was used to process the transcriptome data to calculate the abundance of activated mast cell in each tumor sample.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:36018370", "locator": "sections[21] \"Activated mast cell is associated with poor prognosis and immunotherapy resistance in melanoma\" paragraph 2", "quote": "The CIBERSORT algorithm was used to process the transcriptome data to calculate the abundance of activated mast cell in each tumor sample."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:36018370", "locator": "sections[3] \"Patients\" paragraph 2", "quote": "The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga)."}], "state": "complete"}, {"id": "claim-target-result", "statement": "Mast cell activation is associated with poor prognosis and immunotherapy resistance in melanoma.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:36018370", "locator": "sections[21] \"Activated mast cell is associated with poor prognosis and immunotherapy resistance in melanoma\" paragraph 3", "quote": "Taken together, these findings suggest that mast cell activation is associated with poor prognosis and immunotherapy resistance in melanoma."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "Mast cell activation is associated with poor prognosis and immunotherapy resistance in melanoma.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:36018370"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE91061"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE91061"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:36018370", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1007/s00262-022-03282-6", "sha256": "sha256:5ef2ddc956750acb517450fc8727ebe2b04c40daff56c9374af868c796fc61aa", "bytes": 35716, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1007/s00262-022-03282-6", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC9947072", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE91061", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE91061", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE91061", "version": null, "note": "The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM2420259", "GSM2420260", "GSM2420261", "GSM2420262", "GSM2420263", "GSM2420264", "GSM2420265", "GSM2420266", "GSM2420267", "GSM2420268", "GSM2420269", "GSM2420270", "GSM2420271", "GSM2420272", "GSM2420273", "GSM2420274", "GSM2420275", "GSM2420276", "GSM2420277", "GSM2420278", "GSM2420279", "GSM2420280", "GSM2420281", "GSM2420282", "GSM2420283", "GSM2420284", "GSM2420285", "GSM2420286", "GSM2420287", "GSM2420288", "GSM2420289", "GSM2420290", "GSM2420291", "GSM2420292", "GSM2420293", "GSM2420294", "GSM2420295", "GSM2420296", "GSM2420297", "GSM2420298", "GSM2420299", "GSM2420300", "GSM2420301", "GSM2420302", "GSM2420303", "GSM2420304", "GSM2420305", "GSM2420306", "GSM2420307", "GSM2420308", "GSM2420310", "GSM2420311", "GSM2420312", "GSM2420313", "GSM2420316", "GSM2420317", "GSM2420318", "GSM2420319", "GSM2420320", "GSM2420323", "GSM2420324", "GSM2420325", "GSM2420326", "GSM2420328", "GSM2420329", "GSM2420331", "GSM2420332", "GSM2420333", "GSM2420334", "GSM2420335", "GSM2420336", "GSM2420337", "GSM2420338", "GSM2420339", "GSM2420340", "GSM2420341", "GSM2420342", "GSM2420343", "GSM2420344", "GSM2420345", "GSM2420346", "GSM2420349", "GSM2420350", "GSM2420351", "GSM2420352", "GSM2420353", "GSM2420354", "GSM2420355", "GSM2420356", "GSM2420357", "GSM2420358", "GSM2420359", "GSM2420360", "GSM2420361", "GSM2420362", "GSM2420363", "GSM2420364", "GSM2420365", "GSM2420366", "GSM2420367", "GSM2420368", "GSM2420369", "GSM2420370", "GSM2420371", "GSM2420372", "GSM2420373", "GSM2420374", "GSM2420375", "GSM2420376"], "sample_count": 109, "group_sizes": null, "group_sizes_basis": null, "platform": "9052", "taxon": "Homo sapiens", "title": "Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE91061 not downloaded", "asset:data:geo:GSE91061 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": null, "specific": null, "label": "CIBERSORT algorithm", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The CIBERSORT algorithm was used to process the transcriptome data to calculate the abundance of activated mast cell in each tumor sample."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "method", "blocked_on": "method:not_determinable", "axes": {"method": {"tier": "R4", "expressible": false, "required_operations": [], "missing_operations": [], "basis": "The reader quoted the method the paper names (CIBERSORT algorithm), but the corpus's method extractor could not map it onto a DSL operation, so the method is published but not expressible."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE91061"], "resolved_accessions": ["GSE91061"], "statements": ["The transcriptome data and clinical information of 407 patients in TCGA-SKCM were derived from The Cancer Genome Atlas (TCGA, https://www.cancer.gov/tcga)."], "basis": "The paper names GSE91061 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:36018370", "data:geo:GSE91061"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE91061"]}, "gaps": ["method:not_determinable"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T18:01:51Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 5, "usage": {"prompt_tokens": 10390, "completion_tokens": 1149, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:36018370", "type": "paper", "label": "pmid:36018370"}, {"id": "source:pmid:36018370", "type": "manuscript", "label": "PMID 36018370 full text"}, {"id": "data:geo:GSE91061", "type": "dataset", "label": "GEO GSE91061"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:36018370", "type": "paper", "label": "pmid:36018370"}, {"id": "source:pmid:36018370", "type": "manuscript", "label": "PMID 36018370 full text"}, {"id": "data:geo:GSE91061", "type": "dataset", "label": "GEO GSE91061"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-36018370", "type": "extraction", "used": ["source:pmid:36018370"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE91061", "type": "accession_resolution", "used": ["data:geo:GSE91061"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:36018370", "parent_hash": "sha256:0017bd2053532168ef1c9532df480c44eab74a145ff0e5ebcc425b3d35c11db5", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:GSE91061 licence not read", "asset:data:geo:GSE91061 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "animal_model", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["he effect of the PD-1 antibody on mast cells in vivo. RESULTS: Bioinformatics analysis showed tha", "d be partially inhibited by cromolyn sodium. In vivo, cromolyn sodium increased the efficacy of P", "1 antibody and cromolyn sodium in vitro. The mouse subcutaneous melanoma model was used to veri", "en the diameter of the tumor was 5–9 mm, the mice were randomly divided into four groups. There wer"], "order_basis": "paper_text_order:734", "id": "assay:1"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ican Type Culture Collection (ATCC). The two cell lines were cultured in 1640 complete medium (10% fetal bovine se", "e Collection (ATCC). The two cell lines were cultured in 1640 complete medium (10% fetal bovine serum"], "order_basis": "paper_text_order:2358", "id": "assay:2"}]}